Tirzepatide CAS:2023788-19-2 Mai Kaya na Masana'anta

An haɓaka Tirzepatide a matsayin mai hana ɗaukar ciki guda biyu ga masu karɓar GLP-1 da kuma masu karɓar polypeptide na ciki (GIP) (Frias et al., 2018). Kamar GLP-1, GIP wani sinadari ne na incretin wanda ke aiki don haifar da fitar insulin. Tirzepatide yana cikin mataki na 3 na ci gaba ga manya masu kiba ko kiba masu fama da rashin lafiya mai alaƙa da nauyi kuma a halin yanzu ana duba shi a matsayin magani ga manya masu ciwon suga na nau'in 2. Ana kuma nazarinsa a matsayin magani mai yuwuwa ga steatohepatitis mara barasa (NASH) da gazawar zuciya tare da raguwar fitar da jini (HFpEF).

Yi oda ko Nemi Farashi

Cikakken Bayani game da Samfurin

Alamun Samfura

Aikace-aikace da Tasiri

Ana amfani da Tirzepatide tare da ingantaccen tsarin abinci da motsa jiki don sarrafa yawan sukari a cikin jini ga mutanen da ke da ciwon suga na nau'in 2. Kula da yawan sukari a cikin jini yana taimakawa hana lalacewar koda, makanta, matsalolin jijiyoyi, asarar gaɓoɓi, da matsalolin aikin jima'i. Tirzepatide yana da alaƙa mafi girma da masu karɓar GIP fiye da masu karɓar GLP-1, kuma an nuna cewa wannan halayyar agonist mai ɗaukar nauyi biyu tana haifar da raguwar hauhawar jini idan aka kwatanta da mai karɓar GLP-1 mai zaɓar. Nazarin sigina ya nuna cewa wannan ya faru ne saboda tirzepatide yana kwaikwayon ayyukan GIP na halitta a mai karɓar GIP.

Samfurin Samfuri

Shirya Samfurin:

Ƙarin Bayani:

Tsarin aiki	A'a
Gwaji	99%
Bayyanar	Foda fari
Lambar CAS	2023788-19-2
shiryawa	25KG
Rayuwar shiryayye	Shekaru 2
Ajiya	A adana a wuri mai sanyi da bushewa
Takardar shaida	ISO.